Q2 2025 Brightspring Health Services Inc Earnings Call Transcript
Key Points
- BrightSpring Health Services Inc (BTSG) reported a 29% year-over-year revenue growth, reaching $3.1 billion for the second quarter of 2025.
- The company's adjusted EBITDA grew by 29% compared to the same period last year, driven by strong performance in Onco360 and CareMed Specialty Pharmacy businesses.
- Pharmacy Solutions revenue increased by 32% year-over-year, with specialty scripts growing 38% in the second quarter.
- BrightSpring Health Services Inc (BTSG) increased its 2025 revenue and adjusted EBITDA guidance, reflecting strong performance and positive outlook.
- The company achieved high patient satisfaction scores across various service lines, including a 99% satisfaction score in rehab and a 95% satisfaction score in infusion services.
- The EBITDA margin for the company remained flat at 4.5% compared to the second quarter of last year.
- The preliminary home health rate was deemed inadequate to cover annual expense increases, posing potential challenges for the segment.
- BrightSpring Health Services Inc (BTSG) is facing regulatory scrutiny with the Community Living divestiture, which is subject to FTC review.
- The company is exposed to potential risks from policy changes, such as the IRA and pharma tariffs, which could impact the pharmacy sector.
- A home & community pharmacy customer filed for bankruptcy, although BrightSpring Health Services Inc (BTSG) plans to continue servicing them and has accounted for the impact.
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the BrightSpring Health Services, Inc. second quarter 2025 earnings call. (Operator Instructions).
I would now like to hand the conference over to the first speaker today. You may begin.
Good morning. Thank you for participating in today's conference call. My name is David Deuchler with Investor Relations for BrightSpring. I'm joined on today's call by Jon Rousseau, Chief Executive Officer; and Jen Phipps, Chief Financial Officer. Earlier today, BrightSpring released financial results for the quarter ended June 30, 2025.
A copy of the press release and presentation is available on the company's investor relations website. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance and industry and market conditions. Such forward-looking statements are not
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
